The morbidity and mortality of lung cancer are increasing. The Corona Virus Disease 2019
(COVID-19) is caused by novel coronavirus 2019-nCoV-2, leading to subsequent pulmonary …

COVID-19 and lung cancer are two severe pulmonary diseases that cause millions of deaths
globally each year. Understanding the dysregulated signaling pathways between them can …

Lung cancer is the most common cancer malignancy worldwide. With the continuous spread
of the coronavirus disease 2019 (COVID-19) globally, it is of great significance to explore the …

Patients with lung cancer are presumed to be at high risk from COVID-19 infection due to
underlying malignancy. A total of 31 COVID-19 patients with pre-diagnosed lung cancer and …

Background The coronavirus disease 2019 (COVID-19) pandemic poses a great challenge
to the treatment of lung cancer patients. Materials and methods The PubMed, Embase, and …

Coronavirus disease 2019 (COVID‐19) is spreading worldwide, and has been declared as
an international public health concern. Patients with lung cancer are highly susceptible to …

Simple Summary According to the coronavirus virus resource center of Johns Hopkins
Medicine, more than 75 million people are presently affected worldwide, including 1.7 …

Lung cancer patients with COVID-19 present an increased risk of developing severe
disease and, consequently, have poor outcomes. Determining SARS-CoV-2-host …

Since the outbreak of 2019 novel coronavirus disease (COVID-19) induced by a severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pandemic has become a …

COVID-19 infection caused by SARS-CoV-2 is considered catastrophic because it affects
multiple organs, particularly those of the respiratory tract. Although the consequences of this …